ANI PHARMACEUTICALS INC's ticker is and the CUSIP is 00182CAA1. A total of 22 filers reported holding ANI PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $9,797,000 | -70.0% | 9,000,000 | -66.7% | 21.99% | +73.9% |
| Q2 2019 | $32,706,000 | +230.8% | 27,000,000 | +200.0% | 12.65% | +35.1% |
| Q1 2019 | $9,887,000 | +9.5% | 9,000,000 | 0.0% | 9.36% | -53.4% |
| Q4 2018 | $9,027,000 | -5.3% | 9,000,000 | 0.0% | 20.11% | +27.6% |
| Q3 2018 | $9,530,000 | -6.1% | 9,000,000 | 0.0% | 15.76% | +24.8% |
| Q2 2018 | $10,149,000 | +3.4% | 9,000,000 | 0.0% | 12.63% | -5.2% |
| Q1 2018 | $9,813,000 | – | 9,000,000 | – | 13.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| EVOKE WEALTH, LLC | 3 | $185,000 | 0.00% |